Jun 5 |
Jobs data, Alphabet's new CFO, HPE earnings: Three things
|
Jun 5 |
Alphabet Picks Eli Lilly Executive Anat Ashkenazi As New CFO
|
Jun 5 |
Alphabet taps Eli Lilly executive as new CFO
|
Jun 5 |
Eli Lilly details NASH effects of weight loss drug
|
Jun 5 |
Eli Lilly CFO Anat Ashkenazi to resign
|
Jun 5 |
Alphabet names Lilly veteran Anat Ashkenazi as finance chief
|
Jun 5 |
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
|
Jun 5 |
Lilly announces departure of Anat Ashkenazi, chief financial officer
|
Jun 5 |
Lilly CFO leaves to join Alphabet
|
Jun 4 |
Eli Lilly wins favorable terms for obesity drug use in U.K.
|